3-iodobenzylguanidine has been researched along with Amyloid Deposits in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, D; Algalarrondo, V; Chequer, R; Eliahou, L; Le Guludec, D; Mahida, B; Piekarski, E; Rouzet, F; Slama, MS; Vigne, J | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Amyloid Deposits
Article | Year |
---|---|
Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Amyloid Neuropathies, Familial; Denervation; Diphosphonates; Female; Heart; Humans; Male; Middle Aged; Mutation; Plaque, Amyloid; Prealbumin; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals | 2018 |